脏疾病中的Sirtuins:潜在的机制和治疗点
Qi Jin1, Fang Ma1, Tongtong Liu1
1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Cell communication and signaling : CCS
|February 12, 2024
概括
赛尔图因是一种蛋白质,在细胞健康和衰老中起着关键作用. 调节sirtuin活性显示改善功能和治疗病的前景.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 赛尔图因是NAD+依赖的脱乙酶,对DNA修复和新陈代谢等细胞过程至关重要.
- 异常的Sirtuin表达与与年龄相关的疾病,特别是脏疾病有关.
- 赛尔图因是细胞功能和整体生物体健康的重要调节者.
研究的目的:
- 审查目前对Sirtuins在脏疾病中的作用的理解.
- 探索Sirtuin家族成员,它们的机制和细胞中的功能.
- 为了总结针对sirtuins的治疗策略,以改善脏疾病.
主要方法:
- 关于sirtuins和脏疾病研究的文献综述.
- 对Sirtuin家族成员及其生物机制的分析.
- 调查素在各种细胞类型和疾病背景中的参与.
主要成果:
- 赛尔图因与脏健康相关的多种细胞功能有关,包括DNA修复,炎症和新陈代谢.
- 赛尔图因的失调与各种脏疾病的发病有关.
- 针对Sirtuin活性的特定化合物已经显示出改善损伤的潜力.
结论:
- 针对性调节Sirtuins为脏疾病提供了一个有前途的治疗途径.
- 了解Sirtuin通路为维护功能提供了新的策略.
- 对素激活剂和抑制剂的进一步研究可能会导致对病理的新治疗方法.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
ATP Synthase: Mechanism
14.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.6K
Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics
555
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
555


